MLSS Milestone Scientific
Milestone Scientific earnings company data as of 4:47 AM ET 10/22
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 12 Nov | EPS | — | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 13 Aug | EPS | — | -0.01 | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by MLSS's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $85K sold by 1 insider outside a trading plan
- None no planned (10b5-1) sales
-
S.r.l. Bp4 10% ownerSale$85K 194,427 shares at $0.4400 2.1% of stakeTraded Oct 22–24 Filed Oct 29, 2025
-
S.r.l. Bp4 10% ownerSale$28K 64,034 shares at $0.4400 0.7% of stakeTraded Oct 20–21 Filed Oct 23, 2025
-
S.r.l. Bp4 10% ownerSale$27K 50,158 shares at $0.5400 0.5% of stakeTraded Oct 10–14 Filed Oct 17, 2025
-
S.r.l. Bp4 10% ownerSale$18K 40,000 shares at $0.4600 0.4% of stakeTraded Oct 7–8 Filed Oct 9, 2025
-
S.r.l. Bp4 10% ownerSale$8,636 19,210 shares at $0.4500 0.2% of stakeTraded Oct 3, 2025 Filed Oct 9, 2025
SEC filings
Recent issuer filings from EDGAR, 24 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 10-Q | Filing Doc | ||
| 8-K | 5.02,5.07 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 1.01,5.02,7.01,9.01 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| 424B1 | Filing Doc | ||
| 10-Q | Filing Doc | ||
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K | 4.01,9.01 | Filing Doc | |
| 10-K/A | Filing Doc | ||
| 8-K | 1.01,3.02,9.01 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| 8-K | 5.03,9.01 | Filing Doc | |
| 8-K/A | 9.01 | Filing Doc | |
| 8-K | 1.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.02 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| 8-K | 3.01 | Filing Doc | |
| 10-Q | FORM 10-Q | Filing Doc | |
| 8-K | 5.02,8.01,9.01 | Filing Doc | |
| 8-K | 5.02,7.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.